Jay Backstrom
Patrimonio netto: 4 M $ in data 30/06/2026
Patrimonio netto: 4 M $ in data 30/06/2026
Attualmente, Jay T. Backstrom occupa la posizione di Executive VP & Head-Research & Development presso Acceleron Pharma, Inc. È anche nel consiglio di amministrazione di Autolus Therapeutics Plc. Nella sua carriera passata ha ricoperto la posizione di direttore medico del Samuel U. Rodgers Community Health Center, Inc, Chief Medical Officer per Celgene Corp, Executive Director-Medical & Scientific Services presso Quintiles, Inc. (California) e Vice Presidente-Global Medical & Safety alla Pharmion Corp. Ha ricevuto un dottorato dalla Temple University School of Medicine e una laurea alla St Louis University School of Public Health.
| Società | Data | Numero di azioni | Valutazione | Data di valutazione |
|---|---|---|---|---|
| 26/03/2025 | 76.277 ( 0,07% ) | 4 M $ | 30/06/2026 | |
| 08/07/2026 | 1.447 ( 0% ) | 53 698 $ | 30/06/2026 |
| Società | Posizione | Inizio |
|---|---|---|
| AGIOS PHARMACEUTICALS, INC. | Direttore/Membro del Consiglio | 08/07/2025 |
Be Biopharma, Inc.
Be Biopharma, Inc. Pharmaceuticals: MajorHealth Technology Develops and produces engineered B cell medicines | Direttore/Membro del Consiglio | 16/12/2021 |
Disc Medicine Opco, Inc.
Disc Medicine Opco, Inc. Miscellaneous Commercial ServicesCommercial Services Develops therapies for hematologic diseases | Direttore/Membro del Consiglio | 01/12/2021 |
Pancreatic Cancer Action Network, Inc.
Pancreatic Cancer Action Network, Inc. Medical/Nursing ServicesHealth Services Operates a charity which focuses on the early diagnosis of pancreatic cancer | Direttore/Membro del Consiglio | 01/07/2023 |
| Società | Posizione | Fine |
|---|---|---|
| LAVA THERAPEUTICS | Direttore/Membro del Consiglio | 07/11/2025 |
| SCHOLAR ROCK HOLDING CORPORATION | Amministratore Delegato | 27/04/2025 |
| DISC MEDICINE, INC. | Direttore/Membro del Consiglio | 09/06/2023 |
| AUTOLUS THERAPEUTICS PLC | Direttore/Membro del Consiglio | 28/02/2023 |
| ACCELERON PHARMA INC. | Direttore Tecnico/Scientifico/R&S | 01/12/2021 |
Attive
Inattive
Società nel listino
Aziende private
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
| Aziende private | 16 |
|---|---|
Celgene Corp.
Celgene Corp. BiotechnologyHealth Technology Develops cancer and immunology drugs | Health Technology |
Pharmion Corp.
Pharmion Corp. Pharmaceuticals: MajorHealth Technology Engages in the development and commercialization of products for the treatment of hematology & oncology patients | Health Technology |
Quintiles, Inc. (California)
Quintiles, Inc. (California) Medical/Nursing ServicesHealth Services Provides therapeutic services | Health Services |
Acceleron Pharma, Inc.
Acceleron Pharma, Inc. BiotechnologyHealth Technology Operates as a clinical stage biopharmaceutical company which develops protein therapeutics for cancer and orphan diseases | Health Technology |
Agios Pharmaceuticals, Inc.
Agios Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Discovers and develops therapeutics | Health Technology |
Samuel U. Rodgers Community Health Center, Inc.
Samuel U. Rodgers Community Health Center, Inc. Samuel U. Rodgers Community Health Center, Inc. is a federally qualified nonprofit health organization dedicated to providing affordable healthcare to over 23,000 individuals annually. The private company is based in Kansas City, MO. Established in 1968, the center offers comprehensive services for all ages, including medical care, behavioral health counseling, dental and vision care, telehealth, and health insurance assistance. It provides integrated physical and mental health support, specialized programs for men’s health and maternal and infant health, and services accessible regardless of insurance status. The center is expanding its facilities to address primary care shortages and improve access for vulnerable children, and offers patient education resources, interpretation services in over 40 languages, and community partnerships to enhance care accessibility. | |
Pancreatic Cancer Action Network, Inc.
Pancreatic Cancer Action Network, Inc. Medical/Nursing ServicesHealth Services Operates a charity which focuses on the early diagnosis of pancreatic cancer | Health Services |
St Louis University School of Public Health
St Louis University School of Public Health Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Scholar Rock Holding Corp.
Scholar Rock Holding Corp. BiotechnologyHealth Technology Operates as a biopharmaceutical company that focused on the discovery, development and delivery medicines for neuromuscular, cardiometabolic disorders, cancer, fibrosis and iron-restricted anemia | Health Technology |
Autolus Therapeutics Plc
Autolus Therapeutics Plc Pharmaceuticals: MajorHealth Technology Engages in the development and commercialization of gene therapies | Health Technology |
LAVA Therapeutics NV
LAVA Therapeutics NV Pharmaceuticals: MajorHealth Technology Operates as a biotechnology company that develops antibodies for the treatment of cancer | Health Technology |
Disc Medicine Opco, Inc.
Disc Medicine Opco, Inc. Miscellaneous Commercial ServicesCommercial Services Develops therapies for hematologic diseases | Commercial Services |
Lewis Katz School of Medicine
Lewis Katz School of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Be Biopharma, Inc.
Be Biopharma, Inc. Pharmaceuticals: MajorHealth Technology Develops and produces engineered B cell medicines | Health Technology |
Gemini Therapeutics, Inc.
Gemini Therapeutics, Inc. BiotechnologyHealth Technology Develops drugs for dry age-related macular degeneration and associated rare genetic diseases | Health Technology |
Disc Medicine, Inc.
Disc Medicine, Inc. BiotechnologyHealth Technology Develops therapies addressing red blood cell production in hematologic diseases | Health Technology |
Seleziona la tua edizione
Tutte le informazioni finanziarie adattate in base al livello nazionale